loader
Please Wait
Applying Filters...
Close
4

Coral Megestrol Acetate Coral Megestrol Acetate

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Prestwick3_000956

    Client Email Product
    Menu

    Prestwick3_000956

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    PharmaCompass Sponsored Ads

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ENDO PHARMS INC (5)

    filter

    01 7101576 (1)

    02 9040088 (1)

    03 9101540 (1)

    04 9101549 (1)

    05 9107827 (1)

    filter

    01 Blank (5)

    filter

    01 Y (1)

    02 Blank (4)

    filter

    01 2024-04-22 (5)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    ENDO PHARMS INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MEGESTROL ACETATE

    PDF Supplier PDF
    URL Supplier Web Content
    7101576
    2024-04-22
    U-755
    21778
    TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ENDO PHARMS INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MEGESTROL ACETATE

    PDF Supplier PDF
    URL Supplier Web Content
    9101540
    Y
    2024-04-22
    U-755
    21778
    TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ENDO PHARMS INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MEGESTROL ACETATE

    PDF Supplier PDF
    URL Supplier Web Content
    9107827
    2024-04-22
    U-755
    21778
    TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ENDO PHARMS INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MEGESTROL ACETATE

    PDF Supplier PDF
    URL Supplier Web Content
    9040088
    2024-04-22
    U-755
    21778
    TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    ENDO PHARMS INC

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    MEGESTROL ACETATE

    PDF Supplier PDF
    URL Supplier Web Content
    9101549
    2024-04-22
    U-755
    21778
    TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY